These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6431102)

  • 21. Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivative.
    Karlén A; Johansson AM; Kenne L; Arvidsson LE; Hacksell U
    J Med Chem; 1986 Jun; 29(6):917-24. PubMed ID: 3712382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
    Arvidsson LE; Karlén A; Norinder U; Kenne L; Sundell S; Hacksell U
    J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L; Cornfield LJ; Nelson DL; Hillver SE; Andén NE; Lewander T; Hacksell U
    J Pharmacol Exp Ther; 1991 Jul; 258(1):58-65. PubMed ID: 1830099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indolizidine and quinolizidine derivatives of the dopamine autoreceptor agonist 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP).
    Bøgesø KP; Arnt J; Lundmark M; Sundell S
    J Med Chem; 1987 Jan; 30(1):142-50. PubMed ID: 3806591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo dopamine autoreceptor selectivity appears to be critically dependent upon the aromatic hydroxyl position in a series of N,N-disubstituted 2-aminotetralins.
    Van Oene JC; De Vries JB; Dijkstra D; Renkema RJ; Tepper PG; Horn AS
    Eur J Pharmacol; 1984 Jun; 102(1):101-15. PubMed ID: 6434327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat.
    Svensson K; Alföldi P; Hajós M; Rubicsek G; Johansson AM; Carlsson A; Obál F
    Pharmacol Biochem Behav; 1987 Jan; 26(1):123-9. PubMed ID: 3562484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
    Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. trans-N-n-Propyl-7-hydroxy-octahydrobenzo(f)quinoline, a rigid 3-PPP analogue with greater potency but lack of selectivity for dopamine autoreceptors.
    Van Oene JC; Houwing HA; Dijkstra D; Horn AS
    Eur J Pharmacol; 1983 Mar; 87(4):491-5. PubMed ID: 6406238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
    Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H
    J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S; Sharp T; Hacksell U
    Eur J Pharmacol; 1989 Nov; 170(3):269-74. PubMed ID: 2533557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2-substituted tetralin derivatives as conformationally restricted butyrophenone analogs.
    Chan CC; Farmer PS; McKenzie G; Robertson H
    Pharmazie; 1987 Jun; 42(6):369-71. PubMed ID: 2890175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological profiles of three new, potent and selective dopamine receptor agonists: N-0434, N-0437 and N-0734.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1986 Jun; 125(2):273-82. PubMed ID: 3743637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
    Tricklebank MD; Forler C; Fozard JR
    Eur J Pharmacol; 1984 Nov; 106(2):271-82. PubMed ID: 6241568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ; Bervoets K; Colpaert FC
    J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The enantiomers of the D-2 dopamine receptor agonist N-0437 discriminate between pre- and postsynaptic dopamine receptors.
    Van der Weide J; Tendijck ME; Tepper PG; De Vries JB; Dubocovich ML; Horn AS
    Eur J Pharmacol; 1988 Feb; 146(2-3):319-26. PubMed ID: 2836210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.
    Seiler MP; Stoll AP; Closse A; Frick W; Jaton A; Vigouret JM
    J Med Chem; 1986 Jun; 29(6):912-7. PubMed ID: 3712381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.